Hochschulschrift
Group Sequential and Adaptive Designs for Three-Arm 'Gold Standard' Non-Inferiority Trials
- Alternative title
-
Gruppensequentielle und Adaptive Verfahren für Drei-Armige 'Gold-Standard' Nicht-Unterlegenheitsstudien
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
Bremen, Universität Bremen, Diss., 2014
- Event
-
Veröffentlichung
- (where)
-
Bremen
- (who)
-
Staats- und Universitätsbibliothek Bremen
- (when)
-
2014
- Creator
- Contributor
-
Brannath, Werner
Timm, Jürgen
- URN
-
urn:nbn:de:gbv:46-00103851-12
- Rights
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
14.08.2025, 10:57 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Object type
- Hochschulschrift
Associated
- Schlömer, Patrick
- Brannath, Werner
- Timm, Jürgen
- Staats- und Universitätsbibliothek Bremen
Time of origin
- 2014
Other Objects (12)
Group sequential and adaptive designs for three-arm "Gold-Standard" non-inferiority trials
Planning and analysis of two- and three-arm non-inferiority trials
Testing non-inferiority of a new treatment in three-arm clinical trials with binary endpoints
Understanding the null hypothesis (H0) in non-inferiority trials
Handling an uncertain control group event risk in non-inferiority trials: non-inferiority frontiers and the power-stabilising transformation
Evidence-based sizing of non-inferiority trials using decision models
Phase IV non-inferiority trials and additional claims of benefit
Is there a danger of “biocreep” with non-inferiority trials?
Maximum likelihood theory for retention of effect non-inferiority trials
Non-efficacy benefits and non-inferiority margins: a scoping review of contemporary high-impact non-inferiority trials in clinical cardiology
The use of randomisation-based efficacy estimators in non-inferiority trials
Response to: Understanding the null hypothesis (H0) in non-inferiority trials
Group sequential and adaptive designs for three-arm "Gold-Standard" non-inferiority trials
Planning and analysis of two- and three-arm non-inferiority trials
Testing non-inferiority of a new treatment in three-arm clinical trials with binary endpoints
Understanding the null hypothesis (H0) in non-inferiority trials
Handling an uncertain control group event risk in non-inferiority trials: non-inferiority frontiers and the power-stabilising transformation
Evidence-based sizing of non-inferiority trials using decision models
Phase IV non-inferiority trials and additional claims of benefit
Is there a danger of “biocreep” with non-inferiority trials?
Maximum likelihood theory for retention of effect non-inferiority trials
Non-efficacy benefits and non-inferiority margins: a scoping review of contemporary high-impact non-inferiority trials in clinical cardiology
The use of randomisation-based efficacy estimators in non-inferiority trials
Response to: Understanding the null hypothesis (H0) in non-inferiority trials
Group sequential and adaptive designs for three-arm "Gold-Standard" non-inferiority trials
Planning and analysis of two- and three-arm non-inferiority trials
Testing non-inferiority of a new treatment in three-arm clinical trials with binary endpoints
Understanding the null hypothesis (H0) in non-inferiority trials
Handling an uncertain control group event risk in non-inferiority trials: non-inferiority frontiers and the power-stabilising transformation
Evidence-based sizing of non-inferiority trials using decision models
Phase IV non-inferiority trials and additional claims of benefit
Is there a danger of “biocreep” with non-inferiority trials?
Maximum likelihood theory for retention of effect non-inferiority trials
Non-efficacy benefits and non-inferiority margins: a scoping review of contemporary high-impact non-inferiority trials in clinical cardiology
The use of randomisation-based efficacy estimators in non-inferiority trials